A modern clinic for at-home treatments
(857) 240-1080
Holiday Sale! Get started today for only
$49 $4.99
Written and prepared by:
Lin Hsin, Nirupama Varese, Pei Mun Aui, Bruce D. Wines, Laurent Mascarell, Mark P. Hogarth, Mark Hew, Robyn E. O’Hehir, Menno C. van Zelm
Explore the CytoBas assay's accuracy in detecting house dust mite (HDM) sensitization in asthma and allergic rhinitis. This study highlights the use of fluorescent tetramers of Der p 1 and Der p 2 to stain specific IgE on basophils, achieving over 95% sensitivity and specificity. The CytoBas assay offers a rapid, reliable, and non-invasive method for diagnosing HDM allergies compared to conventional skin prick tests and serum IgE detection.
Study uses CytoBas assay to accurately detect Der p 1 and Der p 2 sensitization in asthma and allergic rhinitis.
CytoBas shows comparable sensitivity and specificity to BAT for detecting house dust mite allergen sensitization.
Combining Der p 1 and Der p 2 in CytoBas assay achieves 100% sensitivity and 96% specificity for house dust mite allergy.
CytoBas offers rapid, accurate allergen detection without the need for in vitro basophil activation, improving clinical utility.
Study emphasizes the importance of using region-specific allergen components for accurate diagnosis of HDM allergy.
CytoBas enables multiplex diagnosis of HDM sensitization, combining major allergen components in a single assay.
Insurance covers clinical consultations.
Subscription fee (from $59/month not billed to insurance) covers immunotherapy, shipping & related costs.